U.S. flag

An official website of the United States government

Display Settings:

Items per page
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 8

1.
Fig. 3

Fig. 3. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

DSC thermograms of a) R-HCl, b) drug-free microspheres (batch F4), and c) drug-loaded microspheres (batch F4)

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

2.
Fig. 1

Fig. 1. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

Phase solubility studies of R-HCl with different cyclodextrin derivatives

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

3.
Fig. 2

Fig. 2. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

FT-IR spectra of a) pure R-HCl powder, b) physical mixture of R-HCl with excipients, and c) R-HCl-loaded microspheres (batch F4)

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

4.
Fig. 5

Fig. 5. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

Scanning electron microscopic view of a) prepared microspheres, b) surface of the microspheres of batch F4

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

5.
Fig. 7

Fig. 7. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

In vitro drug release profile of different batches of the prepared microspheres

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

6.
Fig. 4

Fig. 4. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

X-RD spectra of a) pure R-HCl, b) R-HCl complexed with γ-CD, and c) microspheres composed of complexed drug along with excipients (batch F4)

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

7.
Fig. 6

Fig. 6. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

a) In vitro and b) in vivo mucoadhesion tests of the prepared mucoadhesive microspheres upon stomach and intestinal mucosa of Wistar rats

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

8.
Fig. 8

Fig. 8. From: Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation.

Plasma concentration vs. time (h) profile of the optimized formulation (batch F4) and pure drug powder following oral administration to Wistar rats

Ram K. Jha, et al. AAPS PharmSciTech. 2011 Jun;12(2):650-657.

CitationFull text

Display Settings:

Items per page

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center